Ondine Current Deferred Revenue from 2010 to 2024
| OBI Stock | 8.00 0.13 1.60% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 1.4 M | Current Value 1.4 M | Quarterly Volatility 326.4 K |
Check Ondine Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ondine Biomedical's main balance sheet or income statement drivers, such as Other Operating Expenses of 11.8 M, Total Operating Expenses of 11.2 M or Income Tax Expense of 89.3 K, as well as many indicators such as . Ondine financial statements analysis is a perfect complement when working with Ondine Biomedical Valuation or Volatility modules.
Ondine | Current Deferred Revenue |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Ondine Stock
Ondine Biomedical financial ratios help investors to determine whether Ondine Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ondine with respect to the benefits of owning Ondine Biomedical security.